These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12243702)

  • 1. Keeping psoriasis under wraps.
    Griffiths CE
    J Dermatolog Treat; 2001 Sep; 12(3):133. PubMed ID: 12243702
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a hydrocolloid dressing in combination with a topical steroid in plaque psoriasis.
    Theeuwes M; Bright R
    Cutis; 1996 Jan; 57(1):48-50. PubMed ID: 8620686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobetasol--a potent new topical corticosteroid.
    Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
    [No Abstract]   [Full Text] [Related]  

  • 5. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
    van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
    Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hand dermatosis: a comparative study of a topical glucocorticoid ointment vs solution occluded with a new thin hydrocolloid dressing.
    Beitner H
    Acta Derm Venereol; 1996 Sep; 76(5):408-9. PubMed ID: 8891026
    [No Abstract]   [Full Text] [Related]  

  • 7. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the efficacy of topical corticosteroid: five locally made and one brand name creams.
    Puavilai S; Krisadaphong P; Leenutaphong V; Asawanonda P; Akaraphan R; Ploysangham T; Ruangkarnchanasetr S; Noppakun N; Charuwichitratana S; Kulthanan K; Huiprasert P; Tresukosol P; Ophaswongse S
    J Med Assoc Thai; 2002 Jul; 85(7):789-99. PubMed ID: 12296411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical corticosteroids.
    Med Lett Drugs Ther; 1991 Nov; 33(857):108-10. PubMed ID: 1943979
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psoriasis--the great hidden widespread disease].
    Hedlund I
    Vardfacket; 1991 May; 15(9):II-V. PubMed ID: 1877314
    [No Abstract]   [Full Text] [Related]  

  • 11. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP; AbdulJabbar M
    Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract]   [Full Text] [Related]  

  • 12. Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid.
    Saeki H; Watanabe A; Tada Y; Kakinuma T; Komine M; Ihn H; Asahina A; Etoh T; Kitanaka S; Sato U; Kano H; Igarashi T; Tamaki K
    J Dermatol; 2008 Sep; 35(9):601-3. PubMed ID: 18837708
    [No Abstract]   [Full Text] [Related]  

  • 13. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
    Mommers JM; van Erp PE; van De Kerkhof PC
    Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell vulvitis and response to topical steroids: a case report.
    David L; Massey K
    Int J STD AIDS; 2003 Aug; 14(8):568-9. PubMed ID: 12935388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis update.
    Franz R
    Dermatol Nurs; 2001 Jun; 13(3):231-2. PubMed ID: 11917460
    [No Abstract]   [Full Text] [Related]  

  • 16. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
    Broby-Johansen U; Karlsmark T; Petersen LJ; Serup J
    Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psoriasis bio-assay for topical corticosteroid activity.
    Dumas KJ; Scholtz JR
    Acta Derm Venereol; 1972; 52(1):43-8. PubMed ID: 4111105
    [No Abstract]   [Full Text] [Related]  

  • 20. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment.
    Glade CP; van der Vleuten CJ; van Erp PE; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2002; 15(2):92-9. PubMed ID: 11867965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.